l9n/ North Dakota

2015 Regular Session, 2015–2016

Senate Concurrent Resolution 4016

A concurrent resolution urging Congress and the President of the United States to direct the federal Food and Drug Administration to allow the use of experimental medications to treat Pantothenate kinase-associated neurodegeneration (PKAN) for the benefit of the three children of the Kulsrud family living in Grace City, North Dakota.

Filed with the Secretary of State, on April 7, 2015.

What it does

The synopsis the Legislative Assembly published with the bill.

A concurrent resolution urging Congress and the President of the United States to direct the federal Food and Drug Administration to allow the use of experimental medications to treat Pantothenate kinase-associated neurodegeneration (PKAN) for the benefit of the three children of the Kulsrud family living in Grace City, North Dakota.

Sponsors

Who carried the bill in each chamber, and who signed on. Each name leads to the member's page.

In the Senate

5 co-sponsors

Terry M. Wanzek, Bill Devlin, Craig Headland, Chet Pollert, Don Vigesaa

Votes

Yeas to nays, as the Legislative Assembly recorded them. Committee votes are set in.

  • Human Services6–0

    Do pass · Feb 10

  • Human Services13–0

    Do pass as amended · Mar 18

  • House of Representatives, adoption86–0

    Passed · Mar 20

Amendments

Each amendment offered, and what became of it.

  • House of Representatives committee amendmentAdopted

    Adopted Mar 19

Text

Each version as the Legislative Assembly printed it.

l9n doesn't hold this bill's text yet.

What happened

In l9n's words, one line for each step. Every action as the Legislative Assembly published it is below.

In the Senate Jan 26 – Feb 16

  1. Jan 26Introduced and sent to Human Services
  2. Feb 9Heard in Human Services
  3. Feb 10Human Services recommended it, 6 to 0
  4. Feb 16Adopted in the Senate

In the House of Representatives Feb 17 – Mar 20

  1. Feb 17Arrived in the House of Representatives
  2. Feb 20Read a first time and sent to Human Services
  3. Mar 17Heard in Human Services
  4. Mar 18Human Services recommended it as amended, 13 to 0
  5. Mar 19Amended as the committee recommended
  6. Mar 20Adopted in the House of Representatives, 86 to 0

In the Senate Mar 23 – Apr 1

  1. Mar 23Returned to the Senate
  2. Apr 1The Senate agreed to the other chamber's changes
  3. Adopted in the Senate

In the House of Representatives Apr 6

  1. Apr 6Signed in the House of Representatives

In the Senate Apr 7

  1. Apr 7Signed in the Senate

In both houses Apr 7

  1. Apr 7Filed with the Secretary of State
All 16 actions, as published
  1. Jan 26Introduced, first reading, referred Human Services CommitteeSenate
  2. Feb 9Committee Hearing 09:00Senate
  3. Feb 10Reported back, do pass, place on calendar 6 0 0Senate
  4. Feb 16Second reading, adoptedSenate
  5. Feb 17Received from SenateHouse of Representatives
  6. Feb 20Introduced, first reading, referred Human Services CommitteeHouse of Representatives
  7. Mar 17Committee Hearing 02:30House of Representatives
  8. Mar 18Reported back amended, do pass, amendment placed on calendar 13 0 0House of Representatives
  9. Mar 19Amendment adopted, placed on calendarHouse of Representatives
  10. Mar 20Second reading, adopted as amended yeas 86 nays 0House of Representatives
  11. Mar 23Returned to Senate (12)Senate
  12. Apr 1ConcurredSenate
  13. Apr 1Second reading, adoptedSenate
  14. Apr 6Signed by SpeakerHouse of Representatives
  15. Apr 7Signed by PresidentSenate
  16. Apr 7Filed with Secretary Of State 04/07Both houses